The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis
Open accessAbstract
One of the most common symptoms of Alzheimer's disease (AD) and related tauopathies is memory loss. The exact mechanisms leading to memory loss in tauopathies are not yet known; however, decreased translation due to ribosomal dysfunction has been implicated as a part of this process. Here we use a proteomics approach that incorporates subcellular fractionation and coimmunoprecipitation of tau from human AD and non-demented control brains to identify novel interactions between tau and the endoplasmic reticulum (ER). We show that ribosomes associate more closely with tau in AD than with tau in control brains, and that this abnormal association leads to a decrease in RNA translation. The aberrant tau-ribosome association also impaired synthesis of the synaptic protein PSD-95, suggesting that this phenomenon contributes to synaptic dysfunction. These findings provide novel information about tau-protein interactions in human brains, and they describe, for the first time, a dysfunctional consequence of tau-ribosome associations that directly alters protein synthesis. Significance statement: Despite the identification of abnormal tau-ribosomal interactions in tauopathies >25 years ago, the consequences of this association remained elusive until now. Here, we show that pathological tau associates closely with ribosomes in AD brains, and that this interaction impairs protein synthesis. The overall result is a stark reduction of nascent proteins, including those that participate in synaptic plasticity, which is crucial for learning and memory. These data mechanistically link a common pathologic sign, such as the appearance of pathological tau inside brain cells, with cognitive impairments evident in virtually all tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“m6A is known to accumulate in the cytoplasm in response to stress, but the function of cytoplasmic m6A remains to be clearly delineated (Meier et al., 2016; Briggs et al., 2017; Koren et al., 2019; Ries et al., 2019; Wolozin and Ivanov, 2019; Fu and Zhuang, 2020).”
From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Meier et al., 2016
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
SUnSET, a nonradioactive method to monitor protein synthesis
Schmidt, E. K., Clavarino, G., Ceppi, M., & Pierre, P. (2009) · Nature Methods · doi:10.1038/nmeth.1314 · Cited by 1,706
Migaud, M., Charlesworth, P., Dempster, M., Webster, L. C., Watabe, A. M., Makhinson, M., He, Y., Ramsay, M. F., Morris, R. G. M., Morrison, J. H., et al. (1998) · Nature · doi:10.1038/24790 · Cited by 1,160
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,064
Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
Guo, J. L., & Lee, V. M.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209296 · Cited by 636
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Clos, A. L., Jackson, G. R., & Kayed, R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-39 · Cited by 633
Cited by
Sorted by citations
Stress granules and neurodegeneration
Wolozin, B., & Ivanov, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0222-5 · Cited by 810
Self-citationTau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
Tracy, T. E., Madero‐Pérez, J., Swaney, D. L., Chang, T. S., Moritz, M., Konràd, C., Ward, M. E., Stevenson, E. J., Hüttenhain, R., Kauwe, G., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.041 · Cited by 355
A walk through tau therapeutic strategies
Jadhav, S., Ávila, J., Schöll, M., Kovács, G. G., Kövari, E., Škrabana, R., Evans, L., Kontseková, E., Malawska, B., de Silva, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0664-z · Cited by 299
Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo
Apicco, D. J., Ash, P. E. A., Maziuk, B., LeBlang, C., Medalla, M., Al Abdullatif, A., Ferragud, A., Botelho, E., Ballance, H. I., Dhawan, U., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0022-z · Cited by 281
“Somatodendritic mislocalization would allow tau to interact with RBPs, RNA, and ribosomes, which provides a mechanism through which tau can inhibit protein synthesis 40 .”
Self-citationTau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components
Lester, E., Ooi, F. K., Bakkar, N., Ayers, J. I., Woerman, A. L., Wheeler, J., Bowser, R. P., Carlson, G. A., Prusiner, S. B., & Parker, R. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.026 · Cited by 212
The science of puromycin: From studies of ribosome function to applications in biotechnology
Aviner, R. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.04.014 · Cited by 228
Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196
Li, C., & Götz, J. (2017) · The EMBO Journal · doi:10.15252/embj.201797724 · Cited by 178
Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
Jiang, L., Lin, W., Zhang, C., Ash, P. E. A., Verma, M., Kwan, J., van Vliet, E., Yang, Z., Cruz, A. L., Boudeau, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.038 · Cited by 177
Self-citationBasheer, N., Smolek, T., Hassan, I., Liu, F., Iqbal, K., Zilka, N., & Novak, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02113-z · Cited by 159
RNA binding proteins co-localize with small tau inclusions in tauopathy
Maziuk, B. F., Apicco, D. J., Cruz, A. L., Jiang, L., Ash, P. E. A., da Rocha, E. L., Zhang, C., Yu, W. H., Leszyk, J., Abisambra, J. F., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0574-5 · Cited by 151
Self-citationDysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders
Maziuk, B. F., Ballance, H. I., & Wolozin, B. L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00089 · Cited by 147
Self-citationBuchholz, S., & Zempel, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13784 · Cited by 154
Tau drives translational selectivity by interacting with ribosomal proteins
Koren, S. A., Hamm, M. J., Meier, S. E., Weiss, B. E., Nation, G. K., Chishti, E. A., Arango, J. P., Chen, J., Zhu, H., Blalock, E. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01970-9 · Cited by 122
Self-citationStress granule subtypes: an emerging link to neurodegeneration
Advani, V. M., & Ivanov, P. V. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03565-0 · Cited by 118
Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
Corsi, A., Bombieri, C., Valenti, M. T., & Romanelli, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315383 · Cited by 118
Evans, H. T., Benetatos, J., van Roijen, M., Bodea, L., & Götz, J. (2019) · The EMBO Journal · doi:10.15252/embj.2018101174 · Cited by 112
Moens, T. G., Niccoli, T., Wilson, K. M., Atilano, M. L., Birsa, N., Gittings, L. M., Hölbling, B. V., Dyson, M. C., Thoeng, A., Neeves, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1946-4 · Cited by 110
Mullane, K., & Williams, M. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113945 · Cited by 109
TIA1 regulates the generation and response to toxic tau oligomers
Jiang, L., Ash, P. E. A., Maziuk, B. F., Ballance, H. I., Boudeau, S., Abdullatif, A. A., Orlando, M., Petrucelli, L., Ikezu, T., & Wolozin, B. L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1937-5 · Cited by 100
Self-citationSystematic Analysis and Biomarker Study for Alzheimer’s Disease
Li, X., Wang, H., Long, J., Pan, G., He, T., Anichtchik, O. V., Belshaw, R. D., Albani, D., Edison, P., Green, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35789-3 · Cited by 93
Dysregulation of RNA Splicing in Tauopathies
Apicco, D. J., Zhang, C., Maziuk, B. F., Jiang, L., Ballance, H. I., Boudeau, S., Ung, C. Y., Li, H., & Wolozin, B. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.093 · Cited by 83
Self-citationCurrent directions in tau research: Highlights from Tau 2020
Sexton, C. E., Snyder, H. M., Beher, D., Boxer, A. L., Brannelly, P., Brion, J., Buée, L., Cacace, A. M., Chételat, G., Citron, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12452 · Cited by 89
Waldherr, S. M., Strovas, T. J., Vadset, T. A., Liachko, N. F., & Kraemer, B. C. (2019) · Nature Communications · doi:10.1038/s41467-019-12070-3 · Cited by 74
Liu, W., Zhao, L., Blackman, B. A., Parmar, M. S., Wong, M. Y., Woo, T., Yu, F., Chiuchiolo, M. J., Sondhi, D., Kaminsky, S. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2016-16.2016 · Cited by 73
Protein phosphatase 2A and tau: an orchestrated ‘Pas de Deux’
Taleski, G., & Sontag, E. (2017) · FEBS Letters · doi:10.1002/1873-3468.12907 · Cited by 71
Altered ribosomal function and protein synthesis caused by tau
Evans, H. T., Taylor, D. W., Kneynsberg, A., Bodea, L., & Götz, J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01208-4 · Cited by 73
Mendonça, C. F., Kuras, M., Nogueira, F. C. S., Plá, I., Hortobágyi, T., Csiba, L., Palkovits, M., Renner, É., Döme, P., Marko‐Varga, G., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104509 · Cited by 69
Kulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 70
Mirzaei, M., Pushpitha, K., Deng, L., Chitranshi, N., Gupta, V. B., Rajput, R., Mangani, A. S., Dheer, Y., Godinez, A., McKay, M. J., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1479-4 · Cited by 60
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Xu, Y., Uronen, R., & Huttunen, H. J. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.005 · Cited by 64
Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau
Ferrari, L., Stucchi, R., Konstantoulea, K., van de Kamp, G., Kos, R., Geerts, W. J. C., van Bezouwen, L. S., Förster, F. G., Altelaar, M. A. F., Hoogenraad, C. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13745-7 · Cited by 65
Stress Granules and Neurodegenerative Disorders: A Scoping Review
Asadi, M. R., Moslehian, M. S., Sabaie, H., Jalaiei, A., Ghafouri‐Fard, S., Taheri, M. N., & Rezazadeh, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650740 · Cited by 60
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Hyde, V. R., Zhou, C., y Fernández, J. R. M., Chatterjee, K., Ramakrishna, P., Lin, A., Fisher, G. W., Celiker, O. T., Caldwell, J., Bender, O., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115109 · Cited by 61
Saint‐Aubert, L., Almkvist, O., Chiotis, K., Almeida, R., Wall, A. E., & Nordberg, A. K. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0204-z · Cited by 58
A Drosophila Model of Intellectual Disability Caused by Mutations in the Histone Demethylase KDM5
Zamurrad, S., Hatch, H. A. M., Drelon, C., Belálcazar, H. M., & Secombe, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.018 · Cited by 55
Drepper, F., Biernat, J., Kaniyappan, S., Meyer, H. E., Mandelkow, E., Warscheid, B., & Mandelkow�, E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015882 · Cited by 56
How do protein aggregates escape quality control in neurodegeneration?
Koopman, M. B., Ferrari, L., & Rüdiger, S. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.006 · Cited by 54
Integrated analysis of the aging brain transcriptome and proteome in tauopathy
Mangleburg, C. G., Wu, T., Yalamanchili, H. K., Guo, C., Hsieh, Y.-C., Duong, D. M., Dammer, E. B., De Jager, P. L., Seyfried, N. T., Liu, Z., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00405-4 · Cited by 75
Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 48
Montalbano, M., McAllen, S., Sengupta, U., Puangmalai, N., Bhatt, N. N., Ellsworth, A., & Kayed, R. (2019) · Aging Cell · doi:10.1111/acel.13035 · Cited by 46
Evidence for nucleolar dysfunction in Alzheimer’s disease
Nyhus, C., Pihl, M., Hyttel, P., & Hall, V. J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0104 · Cited by 44
Neuronal nuclear tau and neurodegeneration
Antón‐Fernández, A., Vallés‐Saiz, L., Ávila, J., & Hernández, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.015 · Cited by 45
Bottero, V., & Potashkin, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215403 · Cited by 47
RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
Zwierzchowski-Zarate, A. N., Mendoza‐Oliva, A., Kashmer, O. M., Collazo-Lopez, J. E., White, C. L., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102132 · Cited by 48
Lanzillotta, C., Zuliani, I., Tramutola, A., Barone, E., Blarzino, C., Folgiero, V., Caforio, M., Valentini, D., Villani, A., Locatelli, F., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101892 · Cited by 46
Self-citationKoren, S. A., Galvis-Escobar, S., & Abisambra, J. F. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104939 · Cited by 49
Self-citationCorsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 42
The Pathophysiology of Tau and Stress Granules in Disease
Cruz, A. L., Verma, M., & Wolozin, B. L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_26 · Cited by 42
Self-citationWebber, C. J., Lei, S. (., & Wolozin, B. L. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.021 · Cited by 41
Self-citationDistinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
Karikari, T. K., Nagel, D. A., Grainger, A. I., Clarke-Bland, C., Crowe, J. A., Hill, E. J., & Moffat, K. G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00296 · Cited by 41
Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34005-1 · Cited by 43
Self-citationImplications of mRNA translation dysregulation for neurological disorders
Jishi, A., Qi, X., & Miranda, H. C. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.005 · Cited by 40
Papanikolopoulou, K., Roussou, I. G., Gouzi, J. Y., Samiotaki, M. K., Panayotou, G., Turin, L., & Skoulakis, E. M. C. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0391-19.2019 · Cited by 37
TBK1 interacts with tau and enhances neurodegeneration in tauopathy
Abreha, M. H., Ojelade, S. A., Dammer, E. B., McEachin, Z. T., Duong, D. M., Gearing, M., Bassell, G. J., Lah, J. J., Levey, A. I., Shulman, J. M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100760 · Cited by 33
Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation
Wang, C., Terrigno, M., Li, J., Distler, T., Pandya, N. J., Ebeling, M., Tyanova, S., Hoozemans, J. J. M., Dijkstra, A. A., Fuchs, L., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.033 · Cited by 35
Nuclear face of Tau: an inside player in neurodegeneration
Younas, N., Saleem, T., Younas, A., & Zerr, I. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01702-x · Cited by 34
Balaji, V., Kaniyappan, S., Mandelkow�, E., Wang, Y., & Mandelkow, E.-M. (2018) · Autophagy · doi:10.1080/15548627.2018.1509607 · Cited by 33
Ramakrishna, S., Jhaveri, V., Konings, S. C., Nawalpuri, B., Chakraborty, S., Holst, B., Schmid, B., Gouras, G. K., Freude, K., & Muddashetty, R. S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0435-21.2021 · Cited by 34
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
Brody, A. H., Nies, S. H., Guan, F., Smith, L. M., Mukherjee, B., Salazar, S. A., Lee, S., Lam, T. K. T., & Strittmatter, S. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00526-y · Cited by 36
Banerjee, S., Ferdosh, S., Ghosh, A. N., & Barat, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-61777-7 · Cited by 31
Messenger RNA Translation Defects in Neurodegenerative Diseases
Storkebaum, E., Rosenblum, K., & Sonenberg, N. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215795 · Cited by 32
Masi, M., Attanzio, A., Racchi, M., Wolozin, B. L., Borella, S., Biundo, F., & Buoso, E. (2022) · Cells · doi:10.3390/cells11162590 · Cited by 31
Self-citationConnecting the dots: Neuronal senescence, stress granules, and neurodegeneration
Ma, Y., & Farny, N. G. (2023) · Gene · doi:10.1016/j.gene.2023.147437 · Cited by 30
Jiang, L., Zhao, J., Cheng, J., & Wolozin, B. L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.579434 · Cited by 31
Self-citationAging and Alzheimer’s disease connection: Nuclear Tau and lamin A
Gil, L., Niño, S. A., Capdeville, G., & Jiménez-Capdeville, M. E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135741 · Cited by 31
Qiu, T., Luo, X., Shen, Z., Huang, P., Xu, X., Zhou, J., Zhang, M., & Initiative, A. D. N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160403 · Cited by 29
Verstraelen, P., Detrez, J. R., Verschuuren, M., Kuijlaars, J., Nuydens, R., Timmermans, J., & Vos, W. H. D. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00173 · Cited by 28
Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression
Grundman, J., Spencer, B., Sarsoza, F., & Rissman, R. A. (2021) · PLOS ONE · doi:10.1371/journal.pone.0251611 · Cited by 27
Kopach, O., Esteras, N., Wray, S., Abramov, A. Y., & Rusakov, D. A. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04007-w · Cited by 26
Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression
Baquero, J., Varriano, S., Ordonez, M., Kuczaj, P., Murphy, M. R., Aruggoda, G., Lundine, D., Morozova, V., Makki, A. E.-H., Alonso, A. D. C., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00242 · Cited by 26
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
Pawlowski, M., Meuth, S., & Duning, T. (2017) · Diagnostics · doi:10.3390/diagnostics7030042 · Cited by 25
Xue, W., Li, J., Fu, K., & Teng, W. (2020) · BioMed Research International · doi:10.1155/2020/4505720 · Cited by 26
De novo proteomic methods for examining the molecular mechanisms underpinning long-term memory
Evans, H. T., Blackmore, D. G., Götz, J., & Bodea, L. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.12.015 · Cited by 25
Guo, Q., Dammer, E. B., Zhou, M., Kundinger, S. R., Gearing, M., Lah, J. J., Levey, A. I., Shulman, J. M., & Seyfried, N. T. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.623659 · Cited by 27
Tau/DDX6 interaction increases microRNA activity
Chauderlier, A., Gilles, M., Špolcová, A., Caillierez, R., Chwastyniak, M., Kress, M., Drobecq, H., Bonnefoy, E., Pinet, F., Barbieri-Weill, D., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.06.006 · Cited by 26
Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma
Liu, X., Wang, Q., Shao, Z., Zhang, S., Hou, M., Jiang, M., Du, M., Li, J., & Yuan, H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab099 · Cited by 24
Protein Interaction Network Biology in Neuroscience
Basu, A., Ash, P. E. A., Wolozin, B. L., & Emili, A. (2020) · PROTEOMICS · doi:10.1002/pmic.201900311 · Cited by 23
Self-citationTranslational regulation in stress biology
Genuth, N. R., & Dillin, A. G. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01765-z · Cited by 22
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Li, M., Geng, R., Li, C., Meng, F., Zhao, H., Liu, J., Dai, J., & Wang, X. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2021-0009 · Cited by 19
Contribution of Energy Dysfunction to Impaired Protein Translation in Neurodegenerative Diseases
Liu, Y., & Chern, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.668500 · Cited by 20
Increased expression of fragmented tRNA promoted neuronal necrosis
Cao, Y., Liu, K., Xiong, Y., Zhao, C., & Liu, L. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04108-6 · Cited by 21
Long non-coding RNA SNHG8 drives stress granule formation in tauopathies
Bhagat, R., Minaya, M., Renganathan, A., Mehra, M., Marsh, J. A., Martinez, R. J., Eteleeb, A. M., Nana, A. L., Spina, S., Seeley, W. W., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02237-2 · Cited by 23
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
Pir, G. J., Choudhary, B. C., Kaniyappan, S., Chandupatla, R., Mandelkow�, E., Mandelkow, E., & Wang, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1326-z · Cited by 20
Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
Jiang, Y., & MacNeil, L. T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00664-x · Cited by 22
Patel, S., Howard, D., Man, A., Schwartz, D. H., Jee, J., Felsky, D., Pausová, Z., Paus, T., & French, L. (2020) · eNeuro · doi:10.1523/eneuro.0255-20.2020 · Cited by 16
Hossen, F., Sun, G. Y., & Lee, J. C. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.044 · Cited by 19
Sequestration of Ribosome during Protein Aggregate Formation: Contribution of ribosomal RNA
Pathak, B. K., Mondal, S., Banerjee, S., Ghosh, A. N., & Barat, C. (2017) · Scientific Reports · doi:10.1038/srep42017 · Cited by 18
A role of cellular translation regulation associated with toxic Huntingtin protein
Joag, H., Ghatpande, V., Desai, M., Sarkar, M., Raina, A., Shinde, M., Chitale, R., Deo, A., Bose, T., & Majumdar, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03392-y · Cited by 15
Charif, S. E., Luchelli, L., Vila, A., Blaustein, M., & Igaz, L. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.594561 · Cited by 18
Tau, RNA, and RNA-Binding Proteins: Complex Interactions in Health and Neurodegenerative Diseases
Lester, E., & Parker, R. (2023) · The Neuroscientist · doi:10.1177/10738584231154551 · Cited by 16
The autocrine regulation of insulin-like growth factor-1 in human brain of Alzheimer’s disease
Kang, D., Waldvogel, H. J., Wang, A., Fan, D., Faull, R. L. M., Curtis, M. A., Shorten, P. R., & Guan, J. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105191 · Cited by 16
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Libera, J., Wang, Z., Kilci, A., Jenkins, M., Ortiz, A. R., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1372297 · Cited by 15
Self-citationIdentification of key lipid metabolism-related genes in Alzheimer’s disease
Zeng, Y., Cao, S., Li, N., Tang, J., & Lin, G. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01918-9 · Cited by 18
Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease
Zuniga, G., Katsumura, S., Mange, J. D., Ramirez, P., Atrian, F., Morita, M., & Frost, B. E. (2024) · Aging Cell · doi:10.1111/acel.14245 · Cited by 15
Deng, L., Haynes, P. A., Wu, Y., Amirkhani, A., Kamath, K. S., Wu, Y., Pushpitha, K., Gupta, V., Graham, S. L., Gupta, V. B., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.282261 · Cited by 16
Posttranscriptional regulation of neurofilament proteins and tau in health and disease
Yuan, A., & Nixon, R. A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.017 · Cited by 16
Mendelian randomization analyses implicate biogenesis of translation machinery in human agingPreprint
Javidnia, S., Cranwell, S., Mueller, S. H., Selman, C., Tullet, J. M. A., Kuchenbaecker, K. B., & Alic, N. (2022) · Genome Research · doi:10.1101/gr.275636.121 · Cited by 16
Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
da Costa, P. J., Hamdane, M., Buée, L., & Martin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020241 · Cited by 16
Emerging Connections Between Tau and Nucleic Acids
Galas, M., Bonnefoy, E., Buée, L., & Lefebvre, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_12 · Cited by 17
Metadata
- Authors
- Meier, S., Bell, M., Lyons, D. N., Rodriguez-Rivera, J., Ingram, A., Fontaine, S. N., Mechas, E., Chen, J., Wolozin, B., LeVine, H., Zhu, H., & Abisambra, J. F.
- Affiliations
- Boston University (US)
- University of Kentucky (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2016-01-20
- Volume
- 36
- Issue
- 3
- Pages
- 1001-1007
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC4719006
- OpenAlex
- W2287813183
- Cited by
- 190
- References
- 35
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 13 · 2023: 16 · 2022: 23 · 2021: 28 · 2020: 24 · 2019: 23 · 2018: 8 · 2017: 11 · 2016: 5
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense (AZ140097)
- Alzheimer's Association (NIRG-14-322441)
- GlaxoSmithKline
- University of Kentucky (P30 AG028383, AG028383, P30 CA177558)
- National Institutes of Health (AG028 383, NIH/NIMHD L32 MD009205-01, UL1TR000117, L32 MD009205-01, NIH/NINDS 1R01 NS091329-01)
- National Institute on Aging (AG-028383, P30AG028383, NIA P30 AG028383, NIH/NIA P30 AG028383)
- National Cancer Institute (P30CA177558)
- National Institute of General Medical Sciences (P30GM110787, P20GM103486)
- National Institute of Neurological Disorders and Stroke (NS091329, R01NS091329, R01NS077284, P30NS051220)
- National Center for Research Resources (S10RR029127)
- National Center for Advancing Translational Sciences
- National Institute on Minority Health and Health Disparities (L32MD009205-01, L32 MD009205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- pathological tau, Alzheimer's disease, tauopathy, protein synthesis, endoplasmic reticulum, PSD-95, synaptic dysfunction, memory loss, synaptic plasticity
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Brain, Cells, Cultured, Female, Humans, Male, Microsomes, Neurons, Ribosomes, Protein Biosynthesis, tau Proteins, Tauopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
